Megakaryocyte hyperproliferation without GATA1 mutation in foetal liver of a case of Down syndrome with hydrops foetalis

British Journal of Haematology

Volumn 143, Issue 2, 2008, Pages 300-303

  De Vita, Serena ^a   Devoy, Anny ^a   Groet, Juergen ^a   Krušlin, Božo ^b   Kuzmić Prusac, Ivana ^c   Nižetić, Dean ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Down syndrome; Foetal medicine; Hydrops foetalis; Megakaryocytes; Myeloproliferative disorder

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR GATA 1;

ACUTE MEGAKARYOCYTIC LEUKEMIA; AUTOPSY; BONE MARROW CELL; CASE REPORT; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FETUS HYDROPS; FETUS LIVER; GENE MUTATION; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LETTER; LEUKEMIA; LEUKEMOGENESIS; LIVER BIOPSY; MEGAKARYOCYTE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; SPLEEN BIOPSY; TRISOMY 21;

CELL PROLIFERATION; DOWN SYNDROME; FEMALE; GATA1 TRANSCRIPTION FACTOR; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; MEGAKARYOCYTES; MUTATION; SPLEEN;

EID: 52649166735     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07332.x     Document Type: Letter

References (10)

1. Gassas, A., Doyle, J.J., Weitzman, S., Freedman, M.H., Hitzler, J.K., Sharathkumar, A. Dror, Y. (2005) A basic classification and a comprehensive examination of pediatric myeloproliferative syndromes. Journal of Pediatric Hematology/Oncology, 27, 192 196.
2. Groet, J., McElwaine, S., Spinelli, M., Rinaldi, A., Burtscher, I., Mulligan, C., Mensah, A., Cavani, S., Dagna-Bricarelli, F., Basso, G., Cotter, F.E. Nizetic, D. (2003) Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet, 361, 1617 1620.
3. Groet, J., Mulligan, C., Spinelli, M., Serra, A., McElwaine, S., Cotter, F.E., Dagna-Bricarelli, F., Saglio, G., Basso, G. Nizetic, D. (2005) Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome. Blood, 106, 1887 1888.
4. Hitzler, J.K. Zipursky, A. (2005) Origins of leukaemia in children with Down syndrome. Nature Review Cancer, 5, 11 20.
5. McElwaine, S., Mulligan, C., Groet, J., Spinelli, M., Rinaldi, A., Denyer, G., Mensah, A., Cavani, S., Baldo, C., Dagna-Bricarelli, F., Hann, I., Basso, G., Cotter, F.E. Nizetic, D. (2004) Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker. British Journal Haematology, 125, 729 742.
6. Muntean, A.G., Ge, Y., Taub, J.W. Crispino, J.D. (2006) Transcription factor GATA-1 and Down syndrome leukemogenesis. Leukaemia & Lymphoma, 47, 986 997.
7. Rainis, L., Toki, T., Pimanda, J.E., Rosenthal, E., Machol, K., Strehl, S., Gottgens, B., Ito, E. Izraeli, S. (2005) The proto-oncogene ERG in megakaryoblastic leukemias. Cancer Research, 65, 7596 7602.
8. Smrcek, J.M., Baschat, A.A., Germer, U., Gloeckner-Hofmann, K. Gembruch, U. (2001) Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21. Ultrasound in Obstetrics and Gynecology, 17, 403 409.
9. Taub, J.W., Mundschau, G., Ge, Y., Poulik, J.M., Qureshi, F., Jensen, T., James, S.J., Matherly, L.H., Wechsler, J. Crispino, J.D. (2004) Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome. Blood, 104, 1588 1589.
10. Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. Crispino, J.D. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nature Genetics, 32, 148 152.